Dear Editors,
Kidney transplantation remains the treatment of choice for patients with end-stage renal disease (ESRD), with 5-year graft survival rate of 77%–88% [1, 2]. As patient survival improves, retransplantation now represents a growing proportion of transplant activity. Allograft nephrectomy may be required prior to retransplantation to create space for the subsequent kidney allograft [3, 4]. The procedure is challenging due to dense scarring, distortion of surgical planes, and risk of injury to adjacent vascular, neural, and visceral structures [4]. When retransplantation is performed in the same iliac fossa, surgeons must re-enter a hostile operative field, increasing procedural complexity and risk.
We report a novel application of a breast tissue expander to preserve the iliac fossa following allograft nephrectomy in anticipation of staged kidney retransplantation.
A 37-year-old man with type-1 diabetes and ESRD previously underwent simultaneous kidney-pancreas transplantation, with the pancreas in the right iliac fossa and the renal allograft in the left. Following repeated infections, acute cellular rejection and progressive renal dysfunction, he returned to hemodialysis. After identifying a suitable living donor, we planned to extirpate the failed renal allograft and reimplant the living donor kidney back into the left iliac fossa. Recognizing the technical complexity of allograft nephrectomy and the challenges of reopening a re-scarred fossa for repeat transplantation, the surgical team proposed a novel approach: placement of a tissue expander in the resected fossa after graft removal to preserve space and hopefully limit further scar formation (Figures 1A–C). Following completion of the allograft nephrectomy, a breast tissue expander was soaked in iodine solution, filled with 200 mL of diluted tobramycin and placed into the left iliac fossa. The wound was closed in standard fashion. The patient recovered uneventfully and remained stable during the two-month interval prior to retransplantation.
FIGURE 1
At the time of living-donor transplantation, the expander was encountered within a well-formed pseudocapsule. Extraction was straightforward, and the capsule provided a smooth-walled cavity corresponding to the prior graft bed (Figures 1D-F). Notably, the external iliac vessels and bladder were situated outside the borders of the expander and pseudocapsule, necessitating careful posterior dissection through residual scar tissue to obtain access to the vasculature and bladder. The donor kidney was anastomosed to the external iliac vessels in standard fashion. Immediate graft perfusion and urine output were observed following clamp release. The ureteroneocystostomy was completed over a stent without complication. The patient demonstrated immediate graft function and was discharged on postoperative day seven with stable renal function.
Allograft nephrectomy may be required in cases of failed kidney allograft to create space for subsequent retransplantation, either as a staged procedure or performed simultaneously at the time of retransplantation [5]. The operation is often challenging due to scarring and inflammation around the failed graft, which can increase the risk of increased blood loss, injury to muscle, nerve, vasculature and intraabdominal structures [5]. To our knowledge, this is the first case report describing the use of a tissue expander to limit excessive scarring in the iliac fossa and facilitate subsequent dissection for repeat kidney transplantation on the same operative side. While the tissue expander improved access to the implant bed, the pseudocapsule complicated dissection of the pelvic vessels and bladder, which lay outside it.
The choice between simultaneous or staged nephrectomy during kidney retransplantation remains debated. Simultaneous explant and retransplantation has the advantage of minimizing the number of surgeries and avoiding the anephric state [6]. However, this procedure can result in prolonged anesthesia time, increased risk of intraoperative complications and potentially poor hemodynamic states to support kidney retransplantation [6]. The practice at our center is to stage an allograft nephrectomy, when required, two to three months before repeat transplantation. We found that implantation of the tissue expander in the excised space can potentially redirect scar formation to the periphery of the operative field preserving iliac fossa space. Prolonged implantation of tissue expanders is not a new concept in breast reconstructive surgery, as they are often left in situ for between 2–12 months [7]. However, longer periods of implantation are associated with increased scar tissue formation and risk of tissue expander rupture [7]. Immunocompromised patients are at a higher risk of post-operative infection after tissue expander implantation, and in our center all patients considered for retransplantation remain on their maintenance immunosuppression following allograft nephrectomy. In this case, we thoroughly bathed the tissue expander with iodine solution, filled it with diluted tobramycin and gave IV prophylactic meropenem and micafungin at the time of surgery to minimize the risk of bacterial and fungal infection throughout this patient’s course given their past history of infection.
The formation of the pseudocapsule is consistent with previous studies on breast tissue expanders, where capsular contracture is a well-documented phenomenon [8]. The presence of scar tissue around the vessels and bladder underscores the complexity of the fibrotic response. Strategies aimed at reducing pseudocapsule formation, such as antifibrotic agents, may help mitigate scarring and facilitate future dissection, potentially increasing the appeal of tissue expander use. However, the challenges posed by the pseudocapsule were significant enough that our group will likely avoid using tissue expanders in this patient population unless effective strategies to minimize pseudocapsular formation are available.
This case demonstrates a novel application of a tissue expander to preserve iliac fossa space in kidney retransplantation. Although limited to a single case, the technique was feasible and safe, resulting in successful retransplantation with immediate graft function. The pseudocapsule, while helpful in maintaining iliac fossa space, complicated dissection of the iliac vessels and bladder, limiting the broader applicability of this approach at present.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by University British Columbia Research Ethic Board. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
CN and DH contributed to the study design, data collection, manuscript writing and review. AH and AG contributed to manuscript writing and literature review. All authors contributed to the article and approved the submitted version.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
References
1.
HornbergerJCBestJHGarrisonLP. Cost-Effectiveness of Repeat Medical Procedures: Kidney Transplantation as an Example. Med Decis Making (1997) 17(4):363–72. 10.1177/0272989X9701700401
2.
Canadian Institute for Health Information. Annual Statistics on Organ Replacement in Canada, 2012 to 2021. Ottawa: Canadian Institute for Health Information. Available online at: https://www.cihi.ca/en/annual-statistics-on-organ-replacement-in-canada-2012-to-2021 (Accessed January 8, 2025).
3.
ChowaniecYLuyckxFKaramGGlemainPDantalJRigaudJet alTransplant Nephrectomy After Graft Failure: Is It so Risky? Impact on Morbidity, Mortality and Alloimmunization. Int Urol Nephrol (2018) 50(10):1787–93. 10.1007/s11255-018-1960-4
4.
McDonaldM. Allograft Nephrectomy Vs. No Nephrectomy for Failed Renal Transplants. Front Nephrol (2023) 3:1169181. 10.3389/fneph.2023.1169181
5.
LubetzkyMTantisattamoEMolnarMZLentineKLBasuAParsonsRFet alThe Failing Kidney Allograft: A Review and Recommendations for the Care and Management of a Complex Group of Patients. Am J Transpl (2021) 21(9):2937–49. 10.1111/ajt.16717
6.
RasmussenALevineMAMandurahMMSenerALukePP. Staged Vs. Simultaneous Bilateral Nephrectomy and Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Outcomes and Costs. Can Urol Assoc J (2022) 16(12):424–9. 10.5489/cuaj.7816
7.
FujiiTYajimaRKuwanoH. Implications of Long-Term Indwelling of Tissue Expander in Breast Reconstruction: Risk of Expander Rupturing. Anticancer Res (2016) 36(8):4337–40.
8.
IwahiraYNakagamiGSanadaH. Risk Factors for Capsular Contracture After Breast Reconstruction with Tissue Expanders and Silicone Implants in Nonirradiated Patients: A Retrospective Observational Cohort Study. Medicine (Baltimore) (2022) 101(48):e31837. 10.1097/MD.0000000000031837
Summary
Keywords
allograft nephrectomy, end stage kidney disease, kidney transplantation, repeat transplant, tissue expander
Citation
Hosseinzadeh A, Giannou A, Nguan C and Harriman D (2026) Exploring Tissue Expander Utility in Kidney Transplant Allograft Nephrectomy. Transpl. Int. 39:16632. doi: 10.3389/ti.2026.16632
Received
24 March 2026
Revised
01 April 2026
Accepted
02 April 2026
Published
20 April 2026
Volume
39 - 2026
Updates
Copyright
© 2026 Hosseinzadeh, Giannou, Nguan and Harriman.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: David Harriman, david.harriman@ubc.ca
ORCID: Ali Hosseinzadeh orcid.org/0000-0002-9939-0525 Anastasios Giannou orcid.org/0000-0002-4152-4201 Christopher Nguan orcid.org/0000-0002-2063-1112 David Harriman orcid.org/0000-0002-7327-4331
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.